These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7583585)
1. Differing alpha-tocopherol oxidative lability and ascorbic acid sparing effects in buoyant and dense LDL. Tribble DL; Thiel PM; van den Berg JJ; Krauss RM Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):2025-31. PubMed ID: 7583585 [TBL] [Abstract][Full Text] [Related]
2. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. Tribble DL; van den Berg JJ; Motchnik PA; Ames BN; Lewis DM; Chait A; Krauss RM Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1183-7. PubMed ID: 8302851 [TBL] [Abstract][Full Text] [Related]
3. Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Reaven PD; Grasse BJ; Tribble DL Arterioscler Thromb; 1994 Apr; 14(4):557-66. PubMed ID: 8148354 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein. Kontush A; Finckh B; Karten B; Kohlschütter A; Beisiegel U J Lipid Res; 1996 Jul; 37(7):1436-48. PubMed ID: 8827516 [TBL] [Abstract][Full Text] [Related]
5. Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Tribble DL; Rizzo M; Chait A; Lewis DM; Blanche PJ; Krauss RM Am J Med; 2001 Feb; 110(2):103-10. PubMed ID: 11165551 [TBL] [Abstract][Full Text] [Related]
6. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach. Kontush A; Hübner C; Finckh B; Kohlschütter A; Beisiegel U Free Radic Res; 1996 Feb; 24(2):135-47. PubMed ID: 8845914 [TBL] [Abstract][Full Text] [Related]
7. Effects of lovastatin therapy on susceptibility of LDL to oxidation during alpha-tocopherol supplementation. Palomäki A; Malminiemi K; Malminiemi O; Solakivi T Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1541-8. PubMed ID: 10364087 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of oxidation of low-density lipoprotein by a novel antioxidant, BO-653, prepared by theoretical design. Noguchi N; Okimoto Y; Tsuchiya J; Cynshi O; Kodama T; Niki E Arch Biochem Biophys; 1997 Nov; 347(1):141-7. PubMed ID: 9344475 [TBL] [Abstract][Full Text] [Related]
9. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg alpha-tocopherol on the oxidation resistance of atherogenic lipoproteins. Porkkala-Sarataho EK; Nyyssönen MK; Kaikkonen JE; Poulsen HE; Hayn EM; Salonen RM; Salonen JT Am J Clin Nutr; 1998 Nov; 68(5):1034-41. PubMed ID: 9808219 [TBL] [Abstract][Full Text] [Related]
10. The role of copper reduction by alpha-tocopherol in low-density lipoprotein oxidation. Proudfoot JM; Croft KD; Puddey IB; Beilin LJ Free Radic Biol Med; 1997; 23(5):720-8. PubMed ID: 9296448 [TBL] [Abstract][Full Text] [Related]
11. Ascorbic acid inhibits the increase in low-density lipoprotein (LDL) susceptibility to oxidation and the proportion of electronegative LDL induced by intense aerobic exercise. Sánchez-Quesada JL; Jorba O; Payés A; Otal C; Serra-Grima R; González-Sastre F; Ordóñez-Llanos J Coron Artery Dis; 1998; 9(5):249-55. PubMed ID: 9710684 [TBL] [Abstract][Full Text] [Related]
12. Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins. Yeomans VC; Linseisen J; Wolfram G Eur J Nutr; 2005 Oct; 44(7):422-8. PubMed ID: 15827683 [TBL] [Abstract][Full Text] [Related]
13. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Winklhofer-Roob BM; Ziouzenkova O; Puhl H; Ellemunter H; Greiner P; Müller G; van't Hof MA; Esterbauer H; Shmerling DH Free Radic Biol Med; 1995 Dec; 19(6):725-33. PubMed ID: 8582644 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of oxidation of low density lipoprotein by vitamin E and related compounds. Gotoh N; Noguchi N; Tsuchiya J; Morita K; Sakai H; Shimasaki H; Niki E Free Radic Res; 1996 Feb; 24(2):123-34. PubMed ID: 8845913 [TBL] [Abstract][Full Text] [Related]
15. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Sevanian A; Hwang J; Hodis H; Cazzolato G; Avogaro P; Bittolo-Bon G Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):784-93. PubMed ID: 8640406 [TBL] [Abstract][Full Text] [Related]
16. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Bagnati M; Perugini C; Cau C; Bordone R; Albano E; Bellomo G Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):143-52. PubMed ID: 10229669 [TBL] [Abstract][Full Text] [Related]
17. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Jialal I; Vega GL; Grundy SM Atherosclerosis; 1990 Jun; 82(3):185-91. PubMed ID: 2375783 [TBL] [Abstract][Full Text] [Related]
18. alpha-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cells. Nègre-Salvayre A; Mabile L; Delchambre J; Salvayre R Biol Trace Elem Res; 1995; 47(1-3):81-91. PubMed ID: 7779579 [TBL] [Abstract][Full Text] [Related]
19. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite. Thomas SR; Davies MJ; Stocker R Chem Res Toxicol; 1998 May; 11(5):484-94. PubMed ID: 9585479 [TBL] [Abstract][Full Text] [Related]
20. Antioxidant vitamins and low-density-lipoprotein oxidation. Abbey M; Nestel PJ; Baghurst PA Am J Clin Nutr; 1993 Oct; 58(4):525-32. PubMed ID: 8379508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]